Sakar Healthcare Ltd.
BSE: 538377 | Sector: Health care |
NSE: SAKAR | ISIN Code: INE732S01012 |
BSE 05:30 | 01 Jan | Sakar Healthcare Ltd |
NSE 00:00 | 15 Apr | 112.40 |
0.05 (0.04%) |
OPEN
111.00 |
HIGH
113.80 |
LOW
104.25 |
OPEN | |
PREVIOUS CLOSE | |
VOLUME | |
52-Week high | 0.00 |
52-Week low | 0.00 |
P/E | |
Mkt Cap.(Rs cr) | 0 |
Buy Price | |
Buy Qty | |
Sell Price | |
Sell Qty |
Sakar Healthcare Ltd. (SAKAR) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 632.95 | 0.88 | 653.70 | 434.25 | 151863.69 |
Divi's Lab. | 3782.95 | 1.69 | 3913.00 | 2094.60 | 100418.41 |
Dr Reddy's Labs | 4842.45 | 1.29 | 5514.65 | 3613.45 | 80529.94 |
Cipla | 914.20 | 3.28 | 940.00 | 565.90 | 73725.66 |
Aurobindo Pharma | 914.65 | 0.54 | 1023.10 | 497.25 | 53589.34 |
Cadila Health. | 504.00 | 3.16 | 532.05 | 318.10 | 51594.48 |
Biocon | 404.50 | -0.59 | 487.70 | 320.90 | 48540.00 |
Lupin | 1049.75 | 1.21 | 1121.85 | 787.60 | 47627.16 |
Torrent Pharma. | 2566.30 | 0.00 | 3040.00 | 2227.20 | 43426.93 |
Apollo Hospitals | 2990.80 | 0.42 | 3283.90 | 1253.25 | 43001.72 |
Gland Pharma | 2483.30 | -1.93 | 2784.45 | 1701.00 | 40626.79 |
Piramal Enterp. | 1715.05 | 0.00 | 2008.20 | 805.60 | 38682.95 |
Alkem Lab | 2747.45 | -0.26 | 3150.00 | 2223.55 | 32845.76 |
Abbott India | 14941.65 | -0.11 | 18569.00 | 13970.10 | 31751.01 |
Ipca Labs. | 2101.70 | -2.43 | 2455.55 | 1442.65 | 26660.07 |
Glaxosmi. Pharma | 1463.60 | 0.58 | 1805.00 | 1258.00 | 24794.85 |
Dr Lal Pathlabs | 2932.65 | -0.55 | 3398.95 | 1445.50 | 24440.70 |
Pfizer | 5131.65 | 1.17 | 5875.00 | 3940.00 | 23477.30 |
Laurus Labs | 436.35 | -0.75 | 448.50 | 77.25 | 23414.54 |
Syngene Intl. | 572.90 | 1.50 | 644.65 | 273.80 | 22916.00 |
Quick Links for Sakar Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices